Active Ingredient(s): Tisotumab Vedotin-tftv
FDA Approved: * September 20, 2021
Pharm Company: * SEAGEN
Category: Cancer

Tisotumab vedotin, sold under the brand name Tivdak, is an antibody-drug conjugate used to treat cervical cancer.[1] It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. Tisotumab vedotin was approved for medical use in the United States in September 2021.[1][2] It is administered by infusion into a vein every 3 weeks.[1] Tisotumab ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Tivdak 40 mg/4ml Intravenous Injection, Powder, for Solution
NDC: 51144-003
Seagen Inc.

Popular Topics

Tivdak side effects

After first Tivdak treatment I am having trouble getting back on my feet. I am two weeks out and still having trouble ge...

Tivdak effectiveness

My sister is doing very poorly. Has had 2 infusions of Tivdak. Has floored her. Has had a scan awaiting results. Anyone ...